Prenetics Global Ltd is a genomics-driven health sciences company, that is revolutionizing prevention, early detection, and treatment. The company's prevention arm, CircleDNA, uses whole exome sequencing to offer comprehensive consumer DNA tests. Insighta, Its joint venture with scientist Prof. Dennis Lo, underscores the company's unwavering commitment to saving lives through pioneering multi-cancer early detection technologies. Lastly, ACT Genomics, its treatment unit, is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Each of Prenetics' units synergistically enhances its global impact on health, truly embodying Prenetics commitment to 'enhancing life through science'.